View
7
Download
0
Category
Preview:
Citation preview
144
REFERENCES Reference to a journal publication: [1] J. van der Geer, J.A.J. Hanraads, R.A. Lupton,
The art of writing a scientific article, J. Sci. Commun.
163 (2010) 51–59.
Reference to a book: [2] W. Strunk Jr., E.B. White, The Elements of Style, fourth ed.,
Longman, New York, 2000.
Reference to a chapter in an edited book: [3] G.R. Mettam, L.B. Adams, How to
prepare an electronic version of your article, in: B.S. Jones, R.Z. Smith (Eds.),
Introduction to the Electronic Age, E-Publishing Inc., New York, 2009, pp. 281–304.
[1] Hasumati Rahalkar, Historical overview of pharmaceutical Industry and Drug
regulatory affairs, Pharmaceutical Regulatory Affairs. S11 (2012) 1-11.
doi:10.4172/2167-7689.S11-002
[2] J.R. Sharp, The problems of process Validation, Pharma journal. 1 (1986) 43-
5.
[3] S. Chow, Pharmaceutical Validation and Process Controls in Drug
Development, Drug Information Journal. 31 (1997) 1195-201.
[4] Elsie Jatto et al, Tropical Journal of Pharmaceutical Research. 1 (2002) 115-
122.
[5] L. Suntornsuk, Recent advances of capillary electrophoresis in pharmaceutical
analysis, Analytical and Bioanalytical Chemistry. 398(2010) 29-52.
[6] A. Pluym, W.V. Ael,M. De Smet, Capillary electrophoresis in
chemical/pharmaceutical quality control,Trends in Analytical Chemistry.
11(1992) 27-32.
[7] M.H. Simonian, J.A. Smith, Spectrophotometric and colorimetric
determination of protein concentration, in: Current Protocols in Molecular
Biology, Wiley Interscience, New York, 2006, Unit 10.1A, pp. 519.
[8] F.S. Rojas, C.B. Ojeda, Recent development in derivative ultraviolet/visible
absorption spectrophotometry: A review, Analytica Chimica Acta. 635 (2009)
22-44.
[9] C.B. Ojeda, F.S. Rojas, Recent developments in derivative ultraviolet/visible
absorption spectrophotometry, Analytica Chimica Acta. 518 (2004) 1-24.
145
[10] M.D.P.T. Sotomayor, I.L.T. Dias, M.R.V. Lanza, A.B. Moreira, L.T. Kubota,
Application and advances in the luminescence spectroscopy in pharmaceutical
analyses, Quimica Nova, 31(2008) 1755-1774.
[11] A.A. Eiroa, G. de-Armas, J.M. Estela, V. Cerda, Critical approach to
synchronous spectrofluorimetry, Trends in Analytical Chemistry. 29(2010)
885-901.
[12] A.L. Santos, R.M. Takeuchi, N.R. Stradiotto, Electrochemical,
spectrophotometric and liquid chromatographic approaches for analysis of
tropical disease drugs, Current Pharmaceutical Analysis. 5(2009) 69-88.
[13] J.L. Veuthey, Capillary electrophoresis in pharmaceutical and biomedical
analysis, Analytical and Bioanalytical Chemistry. 381(2005)93-95.
[14] James. M. Miller., Chromatography Concepts and Contrasts, second ed.,
John Wiley & Sons, New York, 2005.
[15] J Cazes, R.P.W. Scott, Chromatography Theory, New York Dekker, John
Wiley & Sons, New York, 2002.
[16] J. Sherma, Modern thin layer chromatography, Journal of AOAC
International. 91(2008) 1142-1144.
[17] K. Ferenczi-Fodor, Z. Vegh, A. Nagy-Turak, B. Renger, M. Zeller, Validation
and quality assurance of planar chromatographic procedures in pharmaceutical
analysis, Journal of AOAC International. 84 (2001) 1265-1276.
[18] R. Martino, M. Malet-Martino, V. Gilard, S. Balayssac, Counterfeit drugs:
analytical techniques for their identification, Analytical and Bioanalytical
Chemistry, 398 (2010) 77–92.
[19] B. Dejaegher, Y.V. Heyden, HILIC methods in pharmaceutical analysis,
Journal of Separation Science. 33 (2010) 698-715.
[20] H. Willard, L. Merritt, A. Dean, Instrumental Methods of Analysis, second
ed., CBS publishers and distributors, Delhi, 1986.
[21] M. Martin, G. Guiochon, Effects of high pressures in liquid chromatography,
Journal of Chromatography A. 7(2005) 16-38.
146
[22] Y. Liu, M. Lee, Ultrahigh pressure liquid chromatography using elevated
temperature,Journal of Chromatography. 1104 (2006) 198–202.
[23] S.L. Abidi, High performance liquid chromatography of phosphatidic acids
and related polar lipids, Journal of Chromatography. 587 (1991) 193-203.
[24] M.T.W. Hearn, Ion pair chromatography on normal and reversed phase
systems, Advanced Chromatography. 18 (1980) 59–100.
[25] L.S Ettre, A. Zlatkis, 75 Years of Chromatography a Historical Dialogue, in:
Journal of Chromatography Library (Eds.), Elsevier., Amsterdam, 1979, pp.
155.
[26] T. Schaefer Kuchler, J. Simat, H. Steinhart, Migration of lubricants from food
packagings, Journalof ChromatographyA.1017 (2003) 107–116.
[27] R. K. Iler, Chemistry of Silica,Wiley Interscience, New York, 1979.
[28] G. V. Lisichkin, Chemistry of Modified Surface Compounds, Phys Math Lit,
Moscow, 2003.
[29] K. K. Unger, Porous Silica: Its Properties and Use as Support in Column
Liquid Chromatography, in: Journal of Chromatography Library (Eds.),
Elsevier, Amsterdam, 1979.
[30] G. Watson, Pharmaceutical analysis: A text book for pharmacy students and
pharmaceutical chemists, Churchill, Livingstone, 1999, pp. 240-241.
[31] A. Skoog, M. Donald, Fundamentals of analytical chemistry,Thomson brooks,
2004, PP. 974-975.
[32] J.H. Knox, J.N. Done, A.F. Fell,HighPerformance Liquid Chromatography,
Edinburgh University Press, Edinburgh,1978.
[33] C.F. Simpson, Practical High Performance Liquid Chromatography, Heyden
and Son, London, 1976.
[34] E. Pungor, A Practical Guide to Instrumental Analysis, Boca Raton, CRC
Press,1995.
[35] A.C. Moffat, M.D. Osselton, B. Widdop, Clarkes Analysis of Drugs and
Poisons, Pharmaceutical Press, London,2004.
[36] U.S. Department of Health and Human Services, Food and Drug
Administration, Center for Drug Evaluation and Research, Center for
147
Veterinary Medicine, Guidance for Industry, Bioanalytical Method Validation,
2001.
[37] Validation of chromatographic methods, Reviewer Guidance, U.S.
Department of Health and Human Services, Food and Drug Administration,
Center for Drug Evaluation and Research,1994.
[38] Analytical Procedures and Methods Validation, U.S. Department of Health
and Human Services, Food and Drug Administration, 2000.
[39] G.C. Hokanson, A life cycle approach to the validation of analytical methods
during pharmaceutical product development,in: part I- The initial validation
process, Pharm Tech, 1994, pp. 118‐30.
[40] G.C.Hokanson,, A life cycle approach to the validation of analytical methods
during pharmaceutical product development, in: part II- Changes and the need
for additional validation, Pharm Tech, 1994, pp.92‐100.
[41] International Conference on Harmonization of Technical Requirements for
Registration of Pharmaceuticals for Human Use, Validation of Analytical
Procedures: Text and Methodology, Q2 (R1), 2005.
[42] M.A. Korany, H. Mahgoub, T.F. Ossama, M.M. Hadir, Application of
artificial neural networks for response surface modelling in HPLC method
development, Journal of Advanced Research. 3 (2012) 53–63.
[43] A. Ferrarini, A.L. Huidobro, F. Pellati, C. Barbas, Development and validation
of a HPLC method for the determination of sertraline and three non-chiral
related impurities ,Journal of Pharmaceutical Biomedical Analysis. 53 (2010)
122–129.
[44] M.E. Swartz, M.D.Jone, P.Fowler, M.A. Andrew; Automated HPLC method
development and transfer, Lc Gc North America. 75 (2002) 49-50.
[45] L.R. Synder, J.J. Kirkland, J.L. X. Glajach, In Practical HPLC Methods
Development, John Wiley., New York, 1997, pp. 643-712.
[46] M. Swartz, M.B. Murphy, New Fronties in Chromatography, Am Lab, 2005,
pp. 22-27.
[47] Z. Debebe, S. Nekhai, M. Ashenafi, B.L. David, D.S. Kalinowski, R.G Victor,
W.M. Byrnes, D.R. Richardson, P.K. Karla, Development of a sensitive HPLC
method to measure in vitropermeability of E- and Z-isomeric forms of
148
thiosemicarbazones in Caco-2 monolayers, Journal of Chromatography B. 906
(2012) 25–32.
[48] Fu. Qiang, M. Shou, D. Chien, R. Markovich, A.M. Rustum, Development
and validation of a stability-indicating RPHPLC method for assay of
betamethasone and estimation of its related compounds, Journal of
Pharmaceutical Biomedical Analysis. 51 (2010) 617–625.
[49] A.T. Nguyen, T. Aerts, D.W. Dam, P.P.D. Deyn, Biogenic amines and their
metabolites in mouse brain tissue: Development, optimization and validation
of an analytical HPLC method, Journal of Chromatography B. 878. (2010)
3003–3014.
[50] S. Deng, J.W. Brett, C.J. Jensen, S. Basar, J. Westendorf, Development and
validation of an RP-HPLC method for the analysis of anthraquinones in noni
fruits and leaves, Food Chemistry. 116 (2009) 505–508.
[51] S.K. Sinha, P.K. Shrivastava, Development and validation of a HPLC method
for the simultaneous estimation of amlodipin and telmisartan in
pharmaceutical dosage form, Asia Pacific Journal of Molecular Biology and
Biotechnology. 1 (2012) 312–315.
[52] E.L. Inman, J.K. Frischmann, P.J. Jimenez, G.D. Winkle, M.L. Persinger, B.
S. Rutherford, General method validation guidelines for pharmaceutical
samples, Journal of Chromatographic Science. 25 (1987) 252−256.
[53] V.P. Shah, K.K. Midha, S. Dighe, I.J. McGilverray, J.P. Skey, A. Yacobi, T.
Layoff, C.T. Viswanathan, C.E. Cook, R.D. McDowall, K. A. Pittman, S.
Spector, Quantitative tests of the moiety in bulk active pharmaceutical
ingredient, Pharma Research. 9 (1992) 588−592.
[54] J. Mark Green, A practical guide to analytical method validation, Analytial
Chemistry. 68 (1996) 305A−309A.
[55] D.H. Shewiyo, E. Kaale, P.G. Risha, B. Dejaegher, J.S. Verbeke, Y.V.
Heyden, HPTLC methods to assay active ingredients in pharmaceutical
formulations: A review of the method development and validation steps,
Analytical Journal of Pharmaceutical and Biomedical Analysis. 66 (2012) 11–
23.
[56] M.D. Rockville, General Tests, Chromatography System Suitability, in:
United States Pharmacopeial Convention (USP)., Chapter 621, USP 31, 2009.
149
[57] ISO/IEC, Guide 99 International vocabulary of metrology – Basic and general
concepts and associated terms (VIM), First edition, Geneva-International
Organization for Standardization, 2007.
[58] A.R.C. Hill, S.L. Reynolds, Guidelines for Inhouse validation of analytical
methods for pesticide residues in food and animal feeds, Analyst. 124 (1999)
953-958.
[59] F. Elbarbry, K. Wilby, J. Alcorn, Validation of a HPLC method for the
determination of p-nitrophenol hydroxylase activity in rat hepatic microsomes,
Journal of Chromatography B. 834 (2006) 199–203.
[60] U.S. Pharmacopoeia, Validation of Compendial Methods, USP-26-NF21,
2003.
[61] S. Chandran, R.S.P. Singh, Comparision of various international guidelines for
analytical method validation, Die Pharmazie: An international journal of
pharmaceutical sciences. 62(2007) 4-14.
[62] J.M. Green, A practical gide to analytical method validation, Analtical
Chemistry. 68 (1996) 305A-309A.
[63] D.M. Bliesner, Validating Chromatographic Methods: A Practical Guide. John
Wiley & Sons Inc, Hoboken, New Jersey, 2006.
[64] L.R. Snyder, J. Joseph, Kirkland, L. Joseph, Practical HPLC Method
Development, second Edition, John Wiley & Sons Inc., Hoboken, New Jersey,
2006.
[65] US FDA, General Principles of Validation, Center for Drug Evaluation and
Research, Rockville, MD, 1987.
[66] G. Tranfo, P. Enrico, S. Renata, P. Daniela, Validation of an HPLC/MS/MS
method with isotopic dilution for quantitative determination of trans, trans-
muconic acid in urine samples of workers exposed to low benzene
concentrations, Journal of Chromatography B. 867 (2008) 26–30.
[67] US FDA, Guidelines for Submitting Samples and Analytical Data for Methods
Validation, Center for Drugs and Biologies Department, 2014.
[68] O. Gonzalez, G. Iriarte, N. Ferreiros, M.I. Maguregui, R.M. Alonso, R.M.
Jimenez, Optimization and validation of a SPE-HPLCPDA- fluorescence
method for the simultaneous determination of drugs used in combined
150
cardiovascular therapy in human plasma, Journal of Pharmaceutical
Biomedical. 50 (2009) 630–639.
[69] ICH Q2 (R1), Validation of Analytical Procedures Text and Methodology,
International Conference on Harmonization, IFPMA, Geneva, 2005.
[70] M.T.T. Trani, M.P. Katherine, C. Marlyn, Matrix-specific method validation
for quantitative analysis of vitamin C in diverse foods, Journal of Food
Compost Analysi. 26 (2012) 12–25.
[71] Y.S. Hernandez, L.B. Sanchez, M.M.G. Bedia, T.G. Luis, Determination of
parthenin in Parthenium hysterophorus by means of HPLC-UV: Method
development and validation, Phytochem Letter. 4 (2011) 134–137.
[72] J.M. Green, A practical guide to analytical method validation, Analytical
Chemistry. 68 (1996) 305A-309A.
[73] D.M. Bliesner, Validating Chromatographic Methods, A Practical Guide, John
Wiley & Sons Inc., Hoboken, New Jersey, 2006.
[74] M. Thompson, S.L.R. Ellison, R. Wood, Guidelines for Single Laboratory,
Validation of Methods of Analysis, Pure Applied Chemistry. 74 (2002) 835–
855.
[75] L.R. Snyder, J. Joseph, Kirkland, L. Joseph, Practical HPLC Method
Development, second Edition, John Wiley & Sons Inc, Hoboken, New Jersey,
2006.
[76] Analytical Methods Committee, Analytical Division, The Royal Society of
Chemistry Analyst. 119 (1994) 2363-2366.
[77] M. Thompson, Basic chemometric techniques in atomic spectroscopy,
Analalytical Proc. 27 (1990) 142-144.
[78] P. Araujo, Key aspects of analytical method validation and linearity
evaluation, Journal of Chromatography B. 877 (2009) 2224–2234.
[79] A. Martnez, J. Riu, F.X. Rius, Multiple analytical method comparision using
maximum livelihood principal component analysis and linear regression with
errors in both axes, Analytica Chemica acta. 446 (2001) 147-158.
[80] V.C. Scheilla, De Souza, G. Roberto, A process to assess linearity by ordinary
least squares method, Journal of Analytica Chimica Acta. 552 (2005) 25-35.
[81] AOAC Peer Verified Methods Program, Manual on policies and procedures,
Arlington, VA 1993.
151
[82] L.A. Pasteelnick, Analytical methods validation. In: Nash RA, Berry IR,
Pharmaceutical process validation, second edition, Marcel Dekker Inc, New
York, 1993, pp. 411–428.
[83] Thompson, M.; Ellison, S.L.R.; and Wood, R.; Pure Appl Chem, 74, 2002,
835–855.
[84] Huang Liusheng, Lizak Patricia, Aweeka Francesca, Long Boyle Janel,
Dvorak, C. Christophe, Long-Boyle Janel and Dvorak Christopher C,
Simultaneous determination of fludarabine and clofarabine in human plasma
by LC-MS/MS, Journal of Chromatography B: Analytical Technologies in the
Biomedical and Life Sciences. 960 (2014) 194-199.
[85] R. Ficarra, M.L. Calabro, S. Tommasini, A. Villari, S. Melardi, S. Coppolino,
M. Semreen, P. Ficarra, Determination of fludarabine in a pharmaceutical
formulation by LC, Journal of pharmaceutical and biomedical analysis.
21(1999) 1077-81.
[86] Li. Liwei, Chen. Bangyin, Zhang, Hanping, Determination of fludarabine
phosphate by HPLC, Zhongguo Yaoshi. 8 (2005) 482-483.
[87] Misztal, Genowefa, B. Paw, Determination of fludarabine phosphate in human
plasma using reversed phase high-performance liquid chromatography,
Pharmazie. 51 (1996) 733-734.
[88] A.M. El Didamony, E.A.H Erfan, Cerimetric determination of four
antihypertensive drugs in pharmaceutical preparations, Journal of the Chilean
Chemical Society. 56 (2011) 875-880.
[89] Nagasuri. Ravindra, Singhvi. Indrajeet, Pillai. Sujit, Estimation of diltiazem
hydrochloride from tablet formulation using spectrophotometric methods,
Research Journal of Pharmacy and Technology. 2 (2009) 730-731.
[90] Vidya.V. Gawande, A.V. Chandewar, Development and validation of
spectroscopic method for estimation of diltiazem hydrochloride in solid
dosage form, Journal of Pharmacy Research. 3 (2010) 3032-3033.
[91] C. Bodson, E. Rozet, E. Ziemons, B. Evrard, Ph. Hubert, L. Delattre,
Validation of manufacturing process of DiltiazemHCl tablets by NIR
spectrophotometry, Journal of Pharmaceutical and Biomedical Analysis. 45
(2007) 356-361.
152
[92] H.H. Hassanein, S. Mostafa, M.S. Gomaa, Spectrophotometric methods for
determination of benazepril hydrochloride and diltiazem hydrochloride,
Egyptian Journal of Biomedical Sciences. 17 (2005) 268-282.
[93] N. Rahman, S.N. Hejaz Azmi, Extractive spectrophotometric methods for
determination of diltiazemHCl in pharmaceutical formulations using
bromothymol blue, bromophenol blue and bromocresol green, Journal of
Pharmaceutical and Biomedical Analysis. 24 (2000) 33-41.
[94] M. Ayad Magda,; Shalaby Abdall, E. Abdellatef Hisham, M. Hosny Mervat,
New colorimetric methods for the determination of trazodoneHCl, famotidine,
and diltiazemHCl in their pharmaceutical dosage forms, Analytical and
Bioanalytical Chemistry. 376 (2003) 710-714.
[95] M. Lacroix Pauline, Beaulieu Normand, D. Cyr Terry, Lovering, G. Edward,
High-performance liquid chromatography method for assay of diltiazem
hydrochloride and its related compounds in bulk drug and finished tablets,
Journal of Pharmaceutical Sciences. 78 (1989) 243-6.
[96] Galina. Holloway, Heather. Rowe Joyce, Samir. Wahab, A stability-indicating
HPLC procedure for determination of diltiazem hydrochloride in
extemporaneously compounded oral liquids, Pharmaceutical Technology
Europe, Pharmaceutical Technology Europe. 20 (2008) 38-40, 42-45.
[97] Riddhi. Dave. Maheshbhai, RP-HPLC method development and validation of
etoposide, Journal of Pharmacy Research. 5 (2012) 3618.
[98] YE Hong yang, Simultaneous determination of the content and the related
substances of etoposide implants by HPLC, Anhui Medical and
Pharmaceutical Journal. 2009-07.
DOI: http://en.cnki.com.cn/Article_en/CJFDTotal-AHYY200907016.htm
[99] D. Chow, Stability-indicating high-performance liquid chromatography of
etoposide at various ph conditions using a reversed-phase octyl column,
Journal of Chromatography A. 396 (1987) 217–223.
[100] K Manouilov. Konstantine, A Knight Jennifer, M Davis. Estella, B. Hoie.
Eric, Assay for etoposide in human serum using solid-phase extraction and
high-performance liquid chromatography with fluorescence detection, Journal
of Chromatography B: Biomedical Sciences and Application. 1-2 (2003) 321-
4.
153
[101] M. Munawar. Hayat, Muhammad. Ashraf, Nisar Ur Rehman, Faiz Ul Hassan.
Nasim, Irshad. Ahmad, Jameel. Rahman, Muhammad Saleem, M. Malik
Zubairj, HPLC determination of etoposide in injectable dosage forms, Journal
of the Chilean Chemical Society. 56 (2011) 881-883.
[102] J.J.M. Holthuis, Plasma assay for the antineoplastic agent VP 16-213
(etoposide) using high-performance liquid chromatography with
electrochemical detection, Journal of Pharmaceutical and Biomedical
Analysis. 1 (1983) 89–97.
[103] E. Chamani, Spectroscopic detection of etoposide binding to chromatin
components: The role of histone proteins, Spectrochim Acta A Mol Biomol
Spectroscopy. 133 (2014) 292-9.
[104] Radi. Abd Elgawad, Voltammetric and ultraviolet–visible spectroscopic
studies on the interaction of etoposide with deoxyribonucleic acid,
Electrochemica Acta. 113 (2013) 164-169.
[105] Tavares de Sousa, Rodrigues da Silva, Camila, Pianetti. Gisele, Antonio.
Gerson, Solano, A Gabriela Reis, Spectrophotometric determination of
etoposide from polymeric implant and application in the study of in vitro
release, Profile, Revista Brasileira de Farmacia. 94 (2013) 295-301.
[106] Raza Abida, Aman Akhtar, Bashir Shumaila, Ahmad Bashir, Irfan Javaid, J.
Dev. Mehta, Hardyal S. Gill, Khan. Abad. Alam, Mehboob, Schatzlein, G.
Andreas, RAPID and sensitive liquid chromatographic method for
determination of etoposide in plasma and biological samples, Journal of
Liquid Chromatography & Related Technologies. 36 (2013) 2796-2813.
[107] Solano, Ana Gabriela Reis, Rodrigues da Silva, Gisele Fialho, Silvia Ligorio,
Cunha, Armando da Silva Jr, Pianetti, Gerson Antonio, Development and
validation of a High Performance Liquid Chromatographic method for
determination of etoposide in biodegradable polymeric implants, Quimica
Nova. 35 (2012) 1239-1243.
[108] Ashraf Muhammad, Hayat Muhammad Munawar, Nasim, Faiz Ul Hassan,
Ahmad Irshad, Saleem Muhammad, Rahman Jameel, Development and
validation of RP-HPLC method for the simultaneous determination of
etoposide and cisplatin and its application in quality control of injectable
dosage forms, Journal of the Chemical Society of Pakistan. 34 (2012) 321-
325.
154
[109] M. Munawar. Hayat, Ashraf, Muhammad, Nisar Ur Rehman, Nasim, Faiz
UlHassan, Ahmad. Irshad, Rahman Jameel, Saleem, Muhammad, M.Malik,
Zubair, HPLC determination of etoposide in injectable dosage forms, Journal
of the Chilean Chemical Society. 56 (2011) 881-883.
[110] Cao Yunli, Du Xiaoli, Zhu Zhu, Fu Qiang, HPLC assay for determination of
etoposide in human plasma, Zhongguo Yaoxue Zazhi. 46 (2011) 857-859.
[111] Wang Peng san, Zhou Hao bing, Wu Rong lian, Ye Hong yang, Wang Qing
shun, Wang Shi liang, HPLC determination of etoposide sustained release
implant and its related substances, Zhongguo Xinyao Zazhi, 12 (2003) 355-
357.
[112] Kato Yasuhiro, Mawatari Hideo, Nishimura Shin Ichiro, Sakura Nobuo, Ueda
Kazuhiro, Determination of etoposide serum concentrations in small pediatric
samples by an improved method of reversedphase high-performance liquid
chromatography, Acta Medica Okayama. 57 (2003) 21-24.
[113] Chu Chengding, Xu Jianjian, Zhang Haiyan, Xie Zheng Ye, Hongyang,
Determination of etoposide (VP-16) concentration in plasma after
subcutaneously implanted by reversed-phase high performance liquid
chromatography, Sepu. 21 (2003) 56-59.
[114] Demperio, L. Vincent, Determination of etoposide phosphate intermediates by
gradient liquid chromatography using post column derivatization with
cuprammonium hydroxide, Journal of Chromatography A. 952 (2002) 283-
287.
[115] Pang Shaokun, Zheng Naiyu, A Felix Carolyn, Scavuzzo Jennifer, Boston
Ray, A. Blair Ian, Simultaneous determination of etoposide and its catechol
metabolite in the plasma of pediatric patients by liquid
chromatography/tandem mass spectrometry, Journal of Mass Spectrometry. 36
(2011) 771-781.
[116] F.H. Shirazi, G. Bahrami, D.J. Stewart, E. Tomiak, F. Delorme, D. Noel, R.
Goel, A rapid reversed phase high performance liquid chromatographic
method for determination of etoposide (VP-16) in human plasma, Journal of
Pharmaceutical and Biomedical Analysis. 25 (2001) 353-356.
[117] R. Zhou, M. Frostvik Stolt, E. Liliemark, Determination of etoposide in
human plasma and leukemic cells by high-performance liquid chromatography
155
with electrochemical detection, Journal of Chromatography B: Biomedical
Sciences and Applications. 757 (2001) 135-141.
[118] Peng, Xingsheng, Determination of etoposide phosphate and related substance
by HPLC, Zhongguo Yaoxue Zazhi. 34 (1999) 485-487.
[119] Xie Jianxun, Li Yuzhen, Wang, Pei, Determination of etoposide (VP16) in
human serum by high-performance liquid chromatography, Sepu. 16 (1998)
74-75.
[120] Beaupin, M. Cecile, Darmanaden, Roland, Quality control in a centralized
reconstitution unit of cytotoxic agents: Determination of etoposide using
highperformance thin layer chromatography, Journal of Oncology Pharmacy.
2 (1996) 35-41.
[121] J. Perez Urizar, Y.F Pico, B. Navarro Gonzalez, F.J. Flores Murrieta, G.
Castaneda Hernandez, A new rapid and economical high performance liquid
chromatographic assay with electrochemical detection for the determination of
etoposide (VP-16) in human plasma samples, Journal of Liquid
Chromatography & Related Technologies. 19 (1996) 939-47.
[122] Zhu Guangwen, Liu Huichen, Li Xinfang, Shen Lixia, Guo Qiaolan, Gao
Huiqin, Determination of etoposide in human serum by high performance
liquid chromatography, Sepu. 12 (1994) 206-7.
[123] A. Fleming Ronald, F. Stewart Clinton, High performance liquid
chromatographic determination of etoposide in plasma, Journal of Liquid
Chromatography. 14 (1991) 1275-83.
[124] B.J. Floor, A.E. Klein, N. Muhammad, D. Ross, Stability indicating liquid
chromatographic determination of etoposide and benzyl alcohol in injectable
formulations, Journal of Pharmaceutical Sciences. 74 (1985) 197-200.
[125] M. Rideout James, C. Ayres David, C.K Lim, T.J. Peters, Determination of
etoposide (VP16-213) and teniposide (VM-26) in serum by high performance
liquid chromatography with electrochemical detection, Journal of
Pharmaceutical and Biomedical Analysis. 2 (1984) 125-8.
[126] J. LittlewoodT, A.L. Hutchings, D.P. Bentley, B.P. Spragg, High performance
liquid chromatographic determination of etoposide in plasma using
electrochemical detection, Journal of Chromatography, Journal of
Chromatography, Biomedical Applications. 336 (1984) 434-7.
156
[127] H.H. Ploegmakers, P.A. Moritz, P.J. Toll, W.J. van Oort, Computerized cyclic
voltammetric detection after HPLC of the antineoplastic agents etoposide,
teniposide, adriamycin and its metabolite adriamycinol in urine samples, The
Journal of automatic chemistry. 11 (1989) 106-12.
[128] R. Zhou, M. Frostvik Stolt, E. Lilie mark, Determination of etoposide in
human plasma and leukemic cells by HPLC with electro chemical detection,
Journal of chromatography B, Biomedical sciences and applications. 757
(2001) 135-41.
[129] C. Chen, Highly sensitive liquid chromatography-electrospray mass
spectrometry (LC-MS) method for the determination of etoposide levels in
human serum and plasma, Journal of chromatography B, Biomedical sciences
and applications. 744 (2000) 91-8.
[130] E.J. Eisenberg, W.M. Eickhoff, Determination of etoposide in blood by liquid
chromatography with electrochemical detection, Journal of Chromatography.
621 (1993) 110-4.
[131] G.F. Duncan, R.H. Farmen, H.S. Movahhed, K.A. Pittman, High-performance
liquid chromatographic method for the determination of etoposide in plasma
using electrochemical Detection, Journal of Chromatography. 380 (1985) 357-
65.
[132] P. Mandpe Leenata, Stress degradation studies on Iloperidone and
development of a stability indicating HPLC method for bulk drug and
pharmaceutical dosage form, Der Chemica Sinica. 2 (2011) 230.
[133] R. Venkata Mahesh, Development and validation of UV spectrophotometric
method for quantitative estimation of iloperidone in bulk and pharmaceutical
dosage form, Journal of Pharmacy Research. 5 (2012) 368.
[134] S. Manjula Devi et al, Validation of UV Spectrophotometric and HPLC
Methods for Quantitative determination fIloperidone in Pharmaceutical dosage
forms, International Journal of pharmtech Research. 4 (2012) 576-581.
[135] G. Saravanan, Mohammad, A validated reverse phase high performance liquid
chromatographic assay method for the estimation of iloperidone in bulk and
commercial tablet dosage form, Journal of Chemical and Pharmaceutical
Research. 5 (2013) 506-511.
157
[136] M. Naresh Chandra Reddy, estimation of 6-fluoro-3-(piperidin-4-yl) benzo [d]
isoxazole hydrochloride and 1-(4-(3-chloropropoxy)-3-methoxyphenyl)
ethanone of iloperidone in bulk and dosage form by RP HPLC, IJPBS.
2(2012) 208-217.
[137] M. Jia, Simultaneous determination of iloperidone and its two active
metabolites in human plasma by liquid chromatography-tandem mass
spectrometry application to a pharmacokinetic study, Journal of
Chromatography B. 928 (2013) 52-7.
[138] Huang Hong yong, Zhi Xiao yan, Wang Chuan sheng, Qian Dong li, Shi
Tian yuan, Determination of iloperidone in human plasma by RP-HPLC,
Zhongguo Xinyao Yu Linchuang Zazhi. 32 (2013) 731-734.
[139] Liu Ming zhou, Chen Ping, Li Jie, Wang Ru feng, Jia Fang, Ma Fang,
Zhang Xing chen, Hu Jun, Li Wei yong, Jia Meng meng, Determination of
iloperidone concentration in human plasma by HPLC-MS/MS, Zhongguo
Yiyuan Yaoxue Zazhi. 32 (2012) 1971-1974.
[140] M. Parekh Jignesh, Sanyal Mallika, Manish Yadav, Shrivastav, S. Pranav,
Stable-isotope dilution LC-MS/MS assay for determination of iloperidone and
its two major metabolites, P 88 and P95, in human plasm, application to a
bioequivalence study, Bioanalysis. 5 (2013) 669-86.
[141] Dhara patel, Development and validation of RP-HPLC method for
simultaneous estimation of risperidone and trihexyphenidyl hydrochloride in
tablet dosage forms, International Journal of Pharmaceutical Sciences review
and research. 4 (2010) 85-88.
[142] A.P. Suthar, Determination of Risperidone and forced degradation behavior by
HPLC in tablet dosage form, International Journal of Pharm Tech Research. 1
(2009) 568-574.
[143] S. Kulkarni, G. Chhabra, M. Shivani, Development and validation of UV
Spectrophotometric method for the determination of risperidone in bulk and
tablets formulation, International Journal of Pharmaceutical Chemistry. 1
(2012) 1-10.
[144] S. Dharmaraj Santhosam, An HPLC method for the simultaneous estimation
of risperidone and trihexyphenidyl hydrochloride from bulk and dosage forms,
HYGEIA Journal for Drugs and Medicines. 3 (2011) 29- 33.
158
[145] S.L. Baldania, EP HPLC estimation in tablet dosage forms, Indian journal of
pharmaceutical sciences, Indian Journal of Pharmaceutical Sciences. 702
(2008) 494-497.
[146] Ming zhu Huang, Determination of risperidone in human plasma by HPLC-
MS/MS and its application to a pharmacokinetic study in Chinese volunteers,
Journal of Zhejiang University Science B. 9 (2008) 114-120.
[147] R. Zarna, Stability Indicating HPLC Determination of Risperidone in Bulk
Drug and Pharmaceutical Formulations, International journal of analyticai
chemistry, Article Id 124917 (2011) 6.
[148] I. Akachukwu, N.J Nwodo, C.J Mbah, Spectrophotometric method for
determination of risperidone in pharmaceutical bulk and dosage forms,
International Journal of Pharmacy. 3 (2013) 710-715.
[149] Deepakumari, Hemavathi Nagaraju, Revanasiddappa, Hosakere
Doddarevanna, Use of the charge transfer reactions for the spectrophotometric
determination of risperidone in pure and in dosagE Forms, Journal of
Pharmaceutics. Article Id 792186 (2013) 6.
[150] Ashour Safwan, Kattan Nuha, Sensitive method for the quantitative
determination of risperidone in tablet dosage form by high-performance liquid
chromatography using chlordiazepoxide as internal standard, International
Journal of Biomedical Science. 9 (2013) 91-97.
[151] Sheeja Velayudhan Kutty, Yellinah Hari Babu, S. Greeshma, P.M. Vidhya,
Difference spectrophotometric method for the determination of Risperidone in
bulk and tablet dosage form, Pharma Innovation. 2 (2013) 44-49.
[152] S. Archana, Y. Naga Prasanna, P. Pavitra, D. Santhi Krupa, M. Hema Sri,
Development and validation of spectrophotometric method for determination
of risperidone by MBTH, International Journal of Pharmaceutical Sciences
and Research. 4 (2013) 1116-1119.
[153] B. Narayana, N. Shetty Divya, Development and validation of
spectrophotometric method for the determination of risperidone, Pharmacia
Lettre. 3 (2011) 104-109.
[154] Li Hongxia, Yang Dongjing, Fan Di, Wang Xueqin, Xing Xiangwei,
Determination of Risperidone and 9-hydroxyrisperidone in human plasma by
LC-MS/MS, Huaxi Yaoxue Zazhi. 26 (2011) 369-371.
159
[155] Chen Jianzheng, Liu Xiuying, Zheng Shijun, Content determination of
risperidone dispersible tablet by UV spectrophotometry, Zhongguo Yaofang.
22 (2011) 1906-1908.
[156] Hasan Moynul, Al Masud Abdullh, Ahmed Jamiuddin, Development and
validation of spectrophotometric method for the determination of Risperidone
in bulk drug andpharmaceutical formulation, International Journal of
Pharmaceutical Sciences and Research. 2 (2011) 378-382.
[157] S. Kathirvel Rao, G. Devala, S.V. Satyanarayana, UV spectrophotometric
determination of Risperidone in bulk and its formulation, Asian Journal of
Research in Chemistry. 3 (2010) 151-153.
[158] Duan Xiaotao, Chen Xiaoyan, Zhang Yifan, Zhong Dafang, Determination of
risperidone in human plasma by liquid chromatography tandem mass
spectrometry, Yaoxue Xuebao. 41 (2006) 684-688.
[159] Aravagiri Manickam, R. Marder Stephen, Simultaneous determination of
risperidone and 9-hydroxyrisperidone in plasma by liquid
chromatography/electrospray tandem mass spectrometry, Journal of Mass
Spectrometry. 35 (2000) 718-724.
[160] J.P. Le Moing, S. Edouard, J.C. Levron, Determination of risperidone and 9-
hydroxyrisperidone in human plasma by high-performance liquid
chromatography with electrochemical detection, Journal of Chromatography:
Biomedical Applications. 614 (1993) 333-9.
[161] Locatelli Igor, Mrhar Ales, Grabnar Iztok, Simultaneous determination of
risperidone and 9-hydroxyrisperidone enantiomers in human blood plasma by
liquid chromatography wit electrochemical detection, Journal of
pharmaceutical and biomedical analysis. 50 (2009) 905-10.
[162] Kousoulos Constantinos, Dotsikas Yannis, L. Loukas Yannis, Turbulent flow
and ternary column-switching on-line clean-up system for high-throughput
quantification of risperidone and its main metabolite in plasma by LC-
MS/MS: application to a bioequivalence study, Talanta. 72 (2007) 360-7.
[163] De Meulder Marc, M.M Remmerie Bart, De Vries Ronald, L.A. Sips Luc,
Boom Sandra, W.J Hooijschuur Edwin, C. Vande Merbel Nico, M.M.B.L
Timmerman Philip, Validated LC-MS/MS methods for the determination of
risperidone and the enantiomers of 9-hydroxyrisperidone in human plasma and
160
urine, Journal of chromatography B: Analytical technologies in the biomedical
and life sciences. 870 (2008) 8-16.
[164] B. Cabovska, S.L. Cox, A.A Vinks, Determination of risperidone and
enantiomers of 9-hydroxyrisperidone in plasma by LC-MS/MS, Journal of
chromatography B: Analytical technologies in the biomedical and life
sciences. 852 (2007) 497-504.
[165] Bhatt Jignesh, Subbaiah Gunta, Singh Sadhana, Liquid
chromatography/tandem mass spectrometry method for simultaneous
determination of risperidone and its active metabolite 9-hydroxyrisperidone in
human plasma, Rapid communications in mass spectrometry. 20 (2006) 2109-
14.
[166] Raggi Maria Augusta, Bugamelli Francesca, Sabbioni Cesare, Saracino Maria
Addolorata, Petio Carmine, HPLC-DAD determination of plasma levels of the
antipsychotic risperidone and its main metabolite for toxicological purposes, .
28 (2005) 245-50.
[167] E. Moody David, D. Laycock John, Huang Wei, L. Foltz Rodger, A high-
performance liquid chromatographic-atmospheric pressure chemical
ionization-tandem mass spectrometric method for determination of risperidone
and 9-hydroxyrisperidone in human plasma, Journal of analytical toxicology.
28 (2004) 494-7.
[168] B.M.M. Remmerie, L.L.A Sips, R. De Vries, J. De Jong, A.M. Schothuis,
E.W. Hooijschuur, N.C. van de Merbel, Validated method for the
determination of risperidone and 9-hydroxyrisperidone in human plasma by
liquid chromatography-tandem mass spectrometry, Journal of
chromatography. B, Analytical technologies in the biomedical and life
sciences. 783 (2003) 461-72.
[169] Jia Jingying, Zhang Mengqi, Lu Xiaopei, Lu Chuan, Li Shuijun, Liu Gangyi,
Yu Chen, Determination of risperidone and the enantiomer of 9-
hydroxyrisperidone in human plasma by LC-MS/MS, Zhongguo Linchuang
Yaoxue Zazhi. 19 (2010) 279-282.
[170] Gao Kepan, Chen Jun, Chen Qinghuav, Determination of risperidone and 9-
hydroxyrisperidone in rat plasma by LC-MS/MS, Zhongguo Yiyao Gongye
Zazhi. 41 (2010) 360-362.
161
[171] Mohammad Yunoos, B. Pragati Kumar, Subhani, Development and validated
new reverse phase HPLC method for the determination of risperidone in bulk
and tablet dosage forms, Research Journal of Pharmaceutical, Biological and
Chemical Sciences. 1 (2010), 165-171.
[172] Wen Yuguan, Liao Rifang, Zeng Zhuanping, Zhang Ming, Determination of
risperidone in plasma by LC-ESI-MS/MS, Guangdong Yaoxueyuan Xuebao.
23 (2007) 528-530.
[173] El Henawee, M. Magda, Spectrophotometric methods for the determination of
risperidone in pure and in dosage forms, Mansoura Journal of pharmaceutical
Sciences. 24 (2008) 43-51.
[174] Huang Zhuo, Sha Chun jie, Zhou Feng mei, Wan hui Liu, Yantai Daxue
Xuebao, Determination of risperidone and 9-hydroxyrisperidone in beagle
plasma by LC/MS, Ziran Kexue Yu Gongchengban. 21 (2008) 110-114.
[175] Seyyed Mohsen Foroutan, Afshin Zarghi, Alireza Shafaati, Arash Khoddam,
Rapid high performance liquid chromatographic determination of risperidone
in human plasma, Iranian Journal of Pharmaceutical Research. 5 (2006) 37-40.
[176] Li Zhang, Zheng Jiao, Zouqing Yao, Yan Zhong, Mingkang Zhong, Yunqiu
Yu, The validation of an LC-MS method for the determination of risperidone
and its active metabolite 9- hydroxyrisperidone in human plasma, Journal of
Chromatographia, 61 (2005) 245-251.
[177] Chongming Fu, Dengqin Wang, Ruichen Guo, Maoqin Tang, Simultaneous
determination of risperidone and 9-hydroxyrisperidone in human serum using
RP-HPLC and its clinical Application, Zhongguo Linchuang Yaolixue Zazhi.
17 (2001) 121-124.
[178] A. Avenoso, G. Facciola, M. Salemi, E. Spina, Determination of risperidone
and its major metabolite 9-hydroxyrisperidone in human plasma by reversed-
phase liquid chromatography with ultraviolet detection, Journal of
Chromatography B: Biomedical Sciences and Applications. 746 (2000) 173-
181.
[179] Hong Xiao, Jing Yang, Shining Zhang, Xinbao Zhang, Determination of
risperidone and 9-hydroxyrisperidone in plasma by high performance liquid
chromatography, Sepu. 17 (1999) 395-396.
162
[180] Robert Woestenborghs, Willy Lorreyne, Frank Van Rompaey, Jos Heykants,
Determination of risperidone and 9-hydroxyrisperidone in plasma, urine and
animal tissues by high-performanceliquid chromatography, Journal of
Chromatography, Biomedical Applications. 583 (1992) 223-30.
[181] A. El Sherif Zeinab, El Zeany Badr, M. El Houssini Ola, High performance
liquid chromatographic and thin layer densitometric methods for the
determination of risperidone inthe presence of its degradation products in bulk
powder and in tablets, Journal of pharmaceutical and biomedical analysis. 36
(2005) 975-81.
[182] Lerena Adrian, Berecz Roland, Dorado Pedro, de la Garza Cesar Sanz,
Norberto Maria Jesus, Caceres Macarena, Gutierrez Jose Ramon,
Determination of risperidone and 9-hydroxyrisperidone in human plasma by
liquid chromatography: application to theevaluation of CYP2D6 drug
interactions, Journal of chromatography B: Analytical technologies in the
biomedical and life sciences. 783 (2003) 213-9.
[183] T. Nagasaki, T. Ohkubo, K. Sugawara, N. Yasui, H. Furukori, S. Kaneko,
Determination of risperidone and 9-hydroxyrisperidone in human plasma by
high-performance liquid chromatography: application to therapeutic drug
monitoring in Japanese patients with schizophrenia, Journal of pharmaceutical
and biomedical analysis. 19 (1999) 595-601.
[184] O.V. Olesen, K. Linnet, Simplified high performance liquid chromatographic
method for determination of risperidone and 9-hydroxyrisperidone in serum
from patients comedicated with other psychotropic drugs, Journal of
chromatography B: Biomedical sciences and applications. 698 (1997) 209-16.
[185] Varanasi Murali Balaram, Mushraff Ali Khan, Validated reverse phase HPLC
method for the determination of topotecan in pharmaceutical dosage forms,
Oriental Journal of Chemistry. 25 (2009) 913-922.
[186] A. De Vries Nienke, Mariet Ouwehand, Tessa Buckle, H. Beijnen Jos, van
Tellingen, Olaf, Determination of topotecan in human and mouse plasma and
in mouse tissue homogenates by reversed-phase high-performance liquid
chromatography, Biomedical Chromatography. 21 (2007) 1191-1200.
[187] Walter J Loos, van Zomeren, M. Desiree, Hans Gelderblom, Jaap Verweij,
Kees Nooter, Gerrit Stoter, Alex Sparreboom, Determination of topotecan in
human whole blood and unwashed erythrocytes by high-performance liquid
163
chromatography, Journal of Chromatography B: Analytical Technologies in
the Biomedical and Life Sciences. 766 (2002) 99-105.
[188] M. Boucaud, F. Pinguet, S. Poujol, C. Astre, F. Bressolle, Sensitive high
performance liquid chromatographic fluorescence determination of topotecan
in human plasma and parotid saliva, Journal of Liquid Chromatography &
Related Technologies. 23 (2000) 2373-2390.
[189] W.J. Loos, G. Stoter, J. Verweij, J.H. Schellens, Sensitive high-performance
liquid chromatographic fluorescence assay for the quantitation of topotecan
(SKF 104864-A) and its lactone ring-opened product (hydroxy acid) in human
plasma and urine, Journal of chromatography B: Biomedical applications. 678
(1996) 309-15.
[190] M. Samya, El Gizawy, H. Osama Abdelmageed, A. Omar Mahmoud, M.
Deryea Sayed, M. Ahmed, Abdel Megied, Development and Validation of
HPLC Method for Simultaneous Determination of Amlodipine, Valsartan,
Hydrochlorothiazide in Dosage Form and Spiked Human Plasma, American
Journal of Analytical Chemistry. 3 (2012) 422-430.
[191] M. Farouk, Omar Abd Elaziz, M. Shereen Tawakkol, A. Hemadan, M.
Shehata, Liquid chromatography electro spray ionization tandem mass
spectrometry for simultaneous determination of amlodipine, benazepril and its
active metabolite benazeprilat in human plasma, Analytical Chemistry Letters.
4 (2014) 1-13.
[192] Lv Chan Mei, Chun Min, Fan Long Bu, Rui Chen, Wang Xiao Lu, Rong Li
Ben Jie Wang, Rui Chen Guo, Determination of amlodipine in human plasma
by LC-MS/MS and its bioequivalence study in healthy Chinese subjects,
Pharmacology & Pharmacy. 4 (2013) 191-200.
[193] Li na Zhang, Man Liu, Man Yang, Ali hua Du, Ya nan Zhang, Dan Zhang,
Jing Hang, Xiao lin Wang, Hui chen Lui, Determination of amlodipine
concentration in human plasma by LC-MS/MS method and bioequivalence
study of its tablets, ZhongguoYaofang. 24 (2013) 910-913.
[194] Yan Wang et al, LC-MS/MS determination of amlodipine in human plasma,
Zhipu Xuebao. 33 (2012) 181-185.
[195] Ying Zhou et al, Development and validation of a liquid chromatography
tandem mass spectrometry method for simultaneoud determination of
amlodipine, atovastatin and its metabolities ortho hydroxyl atovastatin and
164
para hydroxyl atovastatin in human plasma and its application in a
bioequivalence study, Journal of Pharmaceutical and Biomedical Analysis. 83
(2013) 101-107.
[196] Mahmoud Yacoub, Abu Awwad Ahmad, Alawi Mahmoud, Arafat Tawfiq,
Simultaneous determination of amlodipine and atorvastatin with its
metabolities, ortho and para hydroxyl atorvastatin in human plasma by LC-
MS/MS, Journal of Chromatography B: Analytical Technologies in the
Biomedical and Life Sciences. 1 (2013) 917-918, 36-47.
[197] Huichao Chang, Li Jinyin, Li Ji, Guan Xiaoduo, Sun Fanlu, Qian Zhongzhi, Bi
Kaishun, Fan Guorong, Simultaneous determination of amlodipine and
bisoprolol in rat plasma by a liquid chromatography/tandem mass
spectrometry method and its application in pharmacokinetic study, Journal of
Pharmaceutical and Biomedical Analysis 71 (2012) 104-110.
[198] Shentu Jianzhong, Fu Lizhi, Zhou Huili, Hu Xing Jiang, Liu Jian, Chen
Junchun, Wu Guolan, Determination of amlodipine in human plasma using
automated online solid phase extraction HPLC tandem mass spectrometry:
Application to a bioequivalence study of Chinese volunteers, Journal of
Pharmaceutical and Biomedical Analysis. 70 (2012) 614-618.
[199] Ta Manh Hung, Nguyen Thi Dung, Pham Thanh Huyen, Determination of
amlodipine in human plasma by chromatography-tandem mass spectrometry,
Tap Chi PhanTich Hoa Ly Va Sinh Hoc. 15 (2010) 8-12.
[200] Liu Wei, Zhang, Qing, Determination of amlodipine besylate and atorvastatin
calcium in human plasma by LC-MS/MS, Yiyao Daobao. 29 (2010) 698-701.
[201] Feng Shi yin, Xiang Jin, Qin Yong ping, Liang Mao zhi, Yu Qin, Nan Feng,
Determination of Amlodipine in human plasma with LC-MS/MS, Huaxi
Yaoxue Zazhi. 24 (2009) 512-514.
[202] Yue Jin, Zhao Xi, Zhang Yanling, He Yingna, Yang Hanyu, Determination of
amlodipine and atorvastatin in dog's plasma by LC-MS/MS, Zhongguo Yiyao
Gongye Zazhi. 40 (2009) 295-297.
[203] Zhang Zhi feng, Li Jing, Xiao Hong tao, Wu Chun lei, Determination of
amlodipine besylate in plasma and its pharmacokinetics by HPLC-MS-MS,
Xinan Minzu Daxue Xuebao, Ziran Kexueban. 35 (2009) 776-780.
165
[204] Zou, Qiaogen, Zhan Ying, Ge Zhengxiang, Wei Ping, Ouyang Pingkai, Liquid
chromatography-mass spectrometry method for the determination of
amlodipine in human plasma and its application in a bioequivalence study,
Arzneimittel Forschung. 59 (2009) 383-391.
[205] Thai Hong Hanh, Cao Thi Cam Tu, Tran Thi Quynh Chi, Nguyen Ngoc Vinh,
Nguyen Duc Tuan, Determination of amlodipine in human plasma by
LC/MS/MS methods, Tap Chi Duoc Hoc. 49 (2009) 25-28.
[206] Yao Wen, Wang Xiaobo, Xi Ronggang, Song Xiaonan, Liu Dan,
Determination of amlodipine in human plasma by LC/MS/MS: application to
bioequivalence and pharmacokinetics study, ZhongguoYiyuanYaoxue Zazhi.
28 (2008) 981-984.
[207] Zou, Jian jun, Zhu Yu bing, Yu Cui xia, Fan Hong wei, Xiao Da wei, Sheng
Hui, Wang Wen tao, Determination of amlodipine in human plasma by HPLC-
MS and study on its bioequivalence, Zhongguo Linchuang Yaoxue Zazhi. 16
(2007) 214-217.
[208] Liu Mei, Zhang Yan, Wen Ai dong, Yang Lin, Li Wei, Yuan Jing, Gao Xiao
hua, Determination of amlodipine in human plasma by LC-MS/MS method
and pharmacokinetics of amlodipine besylate tablets in healthy volunteers,
Zhongguo Linchuang Yaoxue Zazhi. 16 (2007) 211-214.
[209] Gu Hong an, Miao Ji kang, Zhang Shu hua, Liu Yun, Liu Gang yi, Lu Chuan,
Yu Chen, Determination of Amlodipine besylate in human serum by LC-
MS/MS method, Zhongguo Xinyao Yu Linchuang Zazhi. 26 (2007) 737-740.
[210] Zheng Feng, Wu Chun yong, Shao Lin zhi, Qian Xiao ping, Chen Lei, Liu
Wen ying, Gao Shu, Jiang Zhi wen, Determination of amlodipine in human
plasma by LC-ESI-MS/MS method, Zhongguo Yaoxue Zazhi. 41 (2006)
1663-1666.
[211] B. Streel, C. Laine, C. Zimmer, R. Sibenaler, A. Ceccato, Enantiomeric
determination of amlodipine in human plasma by liquid chromatography
coupled to tandem mass spectrometry, Journal of Biochemical and
Biophysical Methods. 54 (2002) 357-368.
[212] Chen Xiaoyan, Luan Yan, Zhong Dafang, Du Zongmin, Determination of
amlodipine in human plasma by liquid chromatography-tandem mass
spectrometry, Yaoxue Xuebao. 36 (2001) 51-54.
166
[213] Yasuda Taeko, Tanaka Mitsuko, Iba Kazuhiko, Quantitative determination of
amlodipine in serum by liquid chromatography with atmospheric pressure
chemical ionization tandem mass spectrometry, Journal of Mass Spectrometry.
31 (1996) 879-884.
[214] Pan Hua Ling, Lin Li Shan, Ding Jue Fang, Chen Xiao Yan, Zhong Da Fang,
Simultaneous determination of amlodipine, benazepril and benazeprilat in
human plasma by LC-HESI/MS/MS method, Acta Pharmaceutica Sinica. 49
(2014) 95-100.
[215] Feng Yan, Zhang Liang, Shen Zheng, Pan Fengyun, Zhang Zhengxing,
Analysis of amlodipine in human plasma by liquid chromatography-mass
spectrometry, Journal of chromatographic science. 40 (2002) 49-53.
[216] P.S. Jain, M.K. Patel, S.B. Bari, S.J. Surana, Development and validation of
HPTLC method for simultaneous determination of amlodipine besylate and
metoprolol succinate in bulk and tablets, Indian Journal of Pharmaceutical
Sciences. 74 (2012) 152-156.
[217] R. Ambadas Rote, K. Sadhana Kande, Development of HPTLC method for
determination of amlodipine besylate and olmesartan medoxomil using human
plasma by liquid liquid extraction, Journal of Analytical and Bioanalytical
Techniques. 2 (2011) 128.
[218] A.B. Thomas, S.N. Jagdale, R.K. Nanda, L.P. Kothapalli, A.D. Deshpande,
Stability indicating HPTLC method for the simultaneous determination of
amlodipine besylate and telmisartan from tablet dosage form, Journal of
Pharmaceutical Research. 10 (2011) 66-72.
[219] K.H. Gopani, S.S. Havele, S.R. Dhaneshwar, Application of high performance
thin layer chromatography densitometry for the simultaneous determination of
amlodipine besylate and lisinopril in bulk drug and tablet formulation,
International Journal of Pharmacy and Technology. 3 (2011) 2353-2367.
[220] Susheel John Varghese, Thengungal Kochupappy Ravi, Quantitative
simultaneous determination of amlodipine, valsartan, and hydrochlorothiazide
in Exforge HCT tablets using HPLC and high performance thin layer
chromatography, Journal of Liquid Chromatography & Related Technologies.
34 (2011) 981-994.
167
[221] Vandana B Patel, Rajnikanta Sahu, Bhumika M Patel, Simultaneous
determination of amlodipine besylate and atorvastatin calcium in
pharmaceutical tablet formulation by high performance thin layer
chromatographic method, International Journal of Chem Tech Research. 3
(2011) 695-698.
[222] K.R. Gupta, S.B. Wankhede, M.R. Tajne, S.G. Wadodkar, Simultaneous
determination of amlodipine and ramipril by high performance thin layer
chromatography, Asian Journal of Chemistry. 19 (2007) 4177-4182.
[223] S.N. Meyyanathan, B. Suresh, HPTLC Method for the Simultaneous
Determination of Amlodipine and Benazepril in Their Formulations, Journal
of Chromatographic Science. 43 (2005) 73-75.
[224] Kaliappan Ilango, Pabbisetty Bala Shanmuga Kumar, Karunanidhi Santhana
Lakshmi, Simple and rapid high-performance thin-layer chromatographic
determination of amlodipine and atenolol in pharmaceutical dosage forms,
Indian Drugs. 37 (2000) 497-499.
[225] K. Ilango, P.B. Kumar, V.R. Vijaya Prasad, Simple and rapid high-
performance thin layer chromatographic determination of amlodipine in
pharmaceutical dosage forms, Indian Journal of Pharmaceutical Sciences. 59
(1997) 336-337.
[226] P.S Jain, M.K. Patel, S.B. Bari, S.J. Surana, Development and Validation of
HPTLC Method for Simultaneous Determination of Amlodipine Besylate and,
Indian journal of pharmaceutical sciences, 74 (2012) 152-6.
[227] YarramRamakoti Reddy, Kakumani Kishore Kumar, M.R.P. Reddy, K.
Mukkanti, Rapid determination of amlodipine besylate and valsartan in
pharmaceutical preparations by stability-indicating ultra performance liquid
chromatography, Analytical Chemistry: An Indian Journal. 11 (2012) 335-
341.
[228] Bathula Shiva N.V. Prasad, Karuna Prasad Devani, Quantitative determination
of Amlodipine in human plasma by ultra performance liquid chromatography
electro spray ionization mass spectrometry: application to a clinical
pharmacokinetic study, Asian Journal of Pharmaceutical and Clinical
Research. 5 (2012) 89-93.
168
[229] Lu Dingqiang, Dang Anwang, Wang Jun, Ling Xiuquan, Li Yanliang, Jia Jing,
Tu Qingbo, NP HPLC separation and determination of amlodipine
enantiomers, Fenxi Ceshi Xuebao. 28 (2009) 1291-1294.
[230] M. Josefsson, B. Norlander, Coupled column chromatography on a Chiral-
AGP phase for determination of amlodipine enantiomers in human plasma: an
HPLC assay with electrochemical detection, Journal of Pharmaceutical and
Biomedical Analysis. 15 (1996) 267-277.
[231] Alnowaiser, Maha Abdalla, Simultaneous determination of amlodipine and
atorvastatin in Caduet tablets using HPLC, American Journal of Applied
Sciences. 10 (2013) 849-852.
[232] Gumustas Mehmet, A. Ozkan Sibel, A validated stability-indicating RP-LC
method for the simultaneous determination of amlodipine and perindopril in
tablet dosage form and their stress degradation behavior under ICH-
recommended stress conditions, Journal of AOAC International. 96 (2013)
751-757.
[233] L. Peikova, B. Tsvetkova, RP-HPLC method for simultaneous determination
of amlodipine besylate and valsartan in pharmaceutical dosage form,
Pharmacia. 60 (2013) 19-23.
[234] A. Hemke, M. Bhure, V. Anjankar, K. Gupta, Validated RP-HPLC method for
simultaneous determination of Amlodipine, Hydrochlorothiazide and
Valsartan in pharmaceutical formulation , International Journal of Pharmacy
and Technology. 5 (2013) 5383-5392.
[235] P. Pandya Gaurang, S. Hitendra Joshi, Development and validation of stability
indicating HPLC assay method for simultaneous determination of amlodipine
besylate, olmesartan medoxomil and hydrochlorothiazide in tablet
formulation, Pharmacia Sinica. 4 (2013) 145-152.
[236] Boyka G. Tsvetkova, Lily P. Peikova, Development and validation of RP-
HPLC method for simultaneous determination of Amlodipine Besylate and
Hydrochlorothiazide in pharmaceutical dosage form, Journal of Chemical and
Pharmaceutical Research. 5 (2013) 271-275.
[237] Jayesh G. Panchal, Ravindra V. Patel, Bhoomika R. Mistry, Shobhana K
Menon, Development and validation of reversed-phase LC method for
simultaneous determination telmisartan, amlodipine and their degradation
169
products in fixed dose combination tablets, Eurasian Journal of Analytical
Chemistry. 7 (2012) 28-42.
[238] Samia M. Gizawy, Loris I. Bebawy, Osama H. Abdelmageed, Mahmoud A.
Omar, Sayed M. Deryea, Abdel Megied, M. Ahmed, High performance liquid
chromatography, TLC-densitometry, and first derivative spectrophotometry
for simultaneous determination of amlodipine and perindopril in bulk powder
and its tablets, Journal of Liquid Chromatography & Related Technologies. 36
(2013) 1323-1339.
[239] D. Varma, P.S.R.C.H.N.P, A. Lakshmana Rao, S.C. Dinda, Validated stability
indicating HPLC method for simultaneous determination of amlodipine and
metoprolol in bulk drug and pharmaceutical formulations, International
Journal of Research in Pharmacy and Chemistry. 2 (2012) 876-884.
[240] W. Nouruddin Ali, S. Nada Abdelwahab, M. Marco Zaki, M. Abdelkawy,
Validated chromatographic methods for simultaneous determination of
Amlodipine besylate and Perindopril Arginine in binary mixtures and in
pharmaceutical dosage form, Journal of Chromatography and Separation
Techniques. 3 (2012) 134.
[241] M. Samya El Gizawy, H. Osama Abdelmageed, A. Mahmoud Omar, M. Sayed
Deryea, M. Ahmed Abdel Megied, Development and validation of HPLC
method for simultaneous determination of amlodipine, valsartan,
hydrochlorothiazide in dosage form and spiked human plasma, American
Journal of Analytical Chemistry. 3 (2012) 422-430.
[242] K. Anandakumar, D. Jothieswari, R. Subathrai, D.V. Santhi, T. Vetrichelvan,
Validated RP-HPLC method for the simultaneous determination of amlodipine
besylate, valsartan, and hydrochlorothiazide in bulk and in pharmaceutical
formulation, Acta Chromatographica. 24 (2012) 37-50.
[243] Hemandra Kumar Sharma, Vinod Sahu, Rahul Sahu, Neha Sengar, Sneha
Kulkerni, Development and validation of a RP-HPLC method for
simultaneous determination of amlodipine besylate and hydrochlorthiazide in
tablet dosage form, International Journal of Research in Pharmacy and
Science. 1 (2011) 66-74.
[244] R.A. Mhaske, D.J. Garole, A.A. Mhaske, S. Sahasrabudhe, RP-HPLC method
for simultaneous determination of Amlodipine Besylate, Valsartan,
170
Telmisartan, Hydrochlorothiazide and Chlorthalidone: application to
commercially available drug products, International Journal of Pharmaceutical
Sciences and Research. 3 (2012) 141-149.
[245] T. Deepan, V. Alekhya, V. Sekar, P. Perumal, M.D. Dhanaraju, High
performance liquid chromatographic method for determination of Amlodipine
besilate and Olmesartan medoxomil in tablet dosage form, International
Journal of Chemical and Pharmaceutical Sciences. 2 (2011) 5-8.
[246] D. Jothieswari, K. Anandakumar, D. Vijaya Santhi, B. Vijayakumar, D. Priya,
B. Stephen Rathinaraj, Validated RP HPLC method for the simultaneous
determination of amlodipine besylate, valsartan and hydrochlorothiazide in
bulk and in pharmaceutical formulation, Journal of Pharmaceutical and
Biomedical Sciences. 4 (2011) 12.
[247] E. Vignaduzzo Silvana, M. Castellano Patricia, S. Kaufman Teodoro,
Development and validation of an HPLC method for the simultaneous
determination of amlodipine, hydrochlorothiazide, and valsartan in tablets of
their novel triple combination and binary pharmaceutical associations, Journal
of Liquid Chromatography & Related Technologies. 34 (2011) 2383-2395.
[248] Bhatia Neela Manish, Deshmane Snehal Jawaharlal, More Harinath Nivrutti,
Choudhari Praffula Balkrishna, Validated RP HPLC method for simultaneous
determination of amlodipine besylate and hydrochlorothiazide from
pharmaceutical preparation and biological samples, Research Journal of
Pharmacy and Technology. 2 (2009) 482-486.
[249] Ashpak Mubarak Tamboli, Naziya Iqbal Khan, Javed Yakub Manure, Sohrab
Akhtar Shaikh, Shrinivas Krishna Mohite, Development and validation of
stability indicating HPLC method for simultaneous determination of
amlodipine besylate and enalapril maleate, International Research Journal of
Pharmacy. 2 (2011) 185-191.
[250] S.M. Eyad Abu Nameh, Khalid Abu Shandi, Munib Saket, Maher Salim, O.M.
Othman, Y. Mohammad, Simultaneous determination of amlodipine besylate
and Valsartan in tablets by high performance liquid chromatography with UV
detection, Jordan Journal of Pharmaceutical Sciences. 4 (2011) 105-113.
171
[251] Dalong Yang, Yimei Ding, Dingqiang Lu, Determination of amlodipine
besylate and valsartan in compound valsartan tablets by HPLC, Zhongguo
Yiyao Gongye Zazhi. 42 (2011) 292-294.
[252] H. Nora Al Shaalan, A. Maha Alnowaiser, Simultaneous determination of
amlodipine besilate and valsartan in pharmaceutical formulation using high
performance liquid chromatography, Journal of Chemical and Pharmaceutical
Research. 2 (2010) 129-134.
[253] A.M. Tamboli, Chetan Chavan, S.K. Mohite, Development and validation of
a RP-HPLC method for simultaneous determination of amlodipine besylate
and enalapril maleate, Journal of Pharmacy Research. 3 (2010) 2564-2567.
[254] Dilek Kul, Burcu Dogan Topal, Tugba Kutucu, Bengi Uslu, A. Sibel Ozkan,
High-performance liquid chromatographic and first derivative of the ratio
spectrophotometric determination of amlodipine and valsartan in their binary
mixtures, Journal of AOAC International. 93 (2010) 882-890.
[255] K.R. Patil, V.P. Rane, J.N. Sangshetti, R.D. Yeole, D.B. Shinde, Stability
Indicating LC Method For the Simultaneous Determination of Amlodipine and
Olmesartan in Dosage Form, Journal of Chromatographic Science. 48 (2010)
601-606.
[256] Nilesh Jain, Ruchi Jain, Jitendra Banweer, Deepak Kumar Jain, Development
and validation of a rapid RP-HPLC method for the determination of
amlodipine besylate and olmesartan medoxomil in their combined tablet
formulation, International Journal of Current Pharmaceutical Research. 2
(2010) 40-43.
[257] B. Gajanan Kasawar, N. Mazahar Farooqui, Simultaneous determination of
amlodipine besylate and benazepril hydrochloride in pharmaceutical dosage
form by LC, Analytical Sciences. 25 (2009) 1495-1498.
[258] K. Raghu Naidu, N. Udhav Kale, S. Murlidhar Shingare, Stability indicating
RP-HPLC method for simultaneous determination of amlodipine and
benazepril hydrochloride from their combination drug product, Journal of
Pharmaceutical and Biomedical Analysis. 39 (2005) 147-155.
[259] J.R. Rao, S.S. Kadam, K.R Mahadik, Reverse phase high performance liquid
chromatographic determination of amlodipine and benazepril HCL in tablets,
Indian Drugs. 39 (2002) 378-381.
172
[260] U.P. Halkar, N.P. Bhandari, S.H. Rane, High performance liquid
chromatographic simultaneous determination of amlodipine and enalapril
maleate, from pharmaceutical preparation, Indian Drugs. 35 (1998) 168-169.
[261] S.S. Zarapkar, S.S Kolte, S.H. Rane, High-performance liquid
chromatographic determination of amlodipine and atenolol, simultaneously,
from pharmaceutical preparationS, Indian Drugs. 34 (1997) 350-353.
[262] A. Moussa Bahia, A. El Zaher Asmaa, A. Mahrouse Marianne, S. Ahmed
Maha, Simultaneous determination of amlodipine besylate and atorvastatin
calcium in binary mixture by spectrofluorimetry and HPLC coupled with
fluorescence detection, Analytical chemistry insights. (2013) 8107-15.
[263] Gumustas Mehmet, A. Ozkan Sibel, A validated stability-indicating RP-LC
method for the simultaneous determination of amlodipine and perindopril in
tablet dosage form and their stress degradation behavior under ICH-
recommended stress conditions, Journal of AOAC International. 96 (2013)
751-7.
[264] Ozdemir Filiz Arioz, Akyuz Atalay, Simultaneous Determination of
Amlodipine and Aliskren in Tablets by High-Performance Liquid
Chromatography, Journal of chromatographic science. 7 (2013)
DOI: 10.1093/chromsci/bmt099
[265] Deepak Sharma, Anurekha Jain, Alankar Shrivastava, Simultaneous
estimation of amlodipine besylate and nebivolol hydrochloride in tablet
dosage forms by reverse phase-high-performance liquid chromatographic
using ultraviolet detection, Pharmaceutical methods. 2 (2011) 9-14.
[266] B. Patel Deval, A. Mehta Falgun, K. Bhatt Kashyap, Simultaneous Estimation
of Amlodipine Besylate and Indapamide in a Pharmaceutical Formulation by a
High Performance Liquid Chromatographic (RP-HPLC) Method,
Scientiapharmaceutica. 80 (2012) 581-90.
[267] Hassan Heidari, Habib Razmi, Abolghasem Jouyban, Hplc determination of
amlodipine in biological fliuids using hollow fiber based liquid- liquid-liquid
microextraction, Journal of Liquid Chromatography & Related Technologies.
35 (2012) 963-976.
[268] D. Helen Leite, R.M. Maria Ines Santoro,M.A. Joao Porto, Pedro Lopez
Garcia, M. Mariana de Almeida,F. Vanessa Tavares, Kedor Hackmann, R.M.
173
Erika, Quantitative determination of amlodipine besylate in tablets by high
performance liquid chromatography and UV spectrophotometry, Latin
American Journal of Pharmacy. 30 (2011) 527-533.
[269] Yu Dong, Xiaoping Qian, Jingjing Sun, Determination of amlodipine besylate
tablets related substances by HPLC, ZhongguoYaopinBiaozhun, 11 (2010)
213-214.
[270] Amrish Sharma, Mukul Tailang, Bhaskar Gupta, Ashish Acharya, RP HPLC
determination of amlodipine in its pharmaceutical dosage forms, Asian Journal
of Research in Chemistry. 3 (2010) 129-131.
[271] A. Ibrahim Alsarra, High performance liquid chromatographic method for
quantitative determination of amlodipine in human plasma and pharmaceutical
dosage form and its application to pharmacokinetic studies, Journal of
Chromatographic Science. 47 (2009) 863-867.
[272] Guojin Xu, Xinchun Li, Determination of amlodipine bensylate and its related
substances by RP-HPLC with ultraviolet detection, Zhongguo Yaoxue Zazhi,
43 (2008) 60-63.
[273] Chengping Li, Xiaoping Yan, Weiguang Shan, HPLC determination of
amlodipine besylate tablets, Yaowu Fenxi Zazhi. 26 (2006) 1878-1879.
[274] F. Gedil Ustun, O. Atay, Quantitative determination of amlodipine containing
pharmaceuticals by IR spectroscopy and HPLC methods, Journal of Faculty of
Pharmacy of Istanbul University. 38 (2006) 37-46.
[275] A. Zarghi, S.M. Foroutan, A. Shafaati, A. Khoddam, Validated HPLC method
for determination of amlodipine in human plasma and its application to
pharmacokinetic studies, Farmaco. 60 (2005) 789-792.
[276] Kanakapura Basavaiah, Umakanthappa Chandrashekar, Paregowda
Nagegowda, Spectrophotometric and high performance liquid
chromatographic determination of amlodipine besylate in pharmaceuticals,
Science Asia. 31 (2005) 13-21.
[277] Yongjiang Wu, Yunxue Pan, Su Zeng, Determination of amlodipine in
CYP3A4 cDNA-expressed cells by HPLC, Zhejiang DaxueXuebao, Yixueban.
32 (2003) 510-513.
[278] Gh Bahrami, Sh Mirzaeei, Simple and rapid HPLC method for determination
of amlodipine in human serum with fluorescence detection and its use in
174
pharmacokinetic studies, Journal of Pharmaceutical and Biomedical Analysis.
36 (2004) 163-168.
[279] R. Klinkenberg, B. Streel, A. Ceccato, Development and validation of a liquid
chromatographic method for the determination of amlodipine residues on
manufacturing equipment surfaces, Journal of Pharmaceutical and Biomedical
Analysis. 32 (2003) 345-352.
[280] S. Tatar, S. Atmaca, Determination of amlodipine in human plasma by high-
performance liquid chromatography with fluorescence detection, Journal of
Chromatography B: Biomedical Sciences and Applications. 758 (2001) 305-
310.
[281] Fei Shang, Kuihong Shang, Determination of amlodipine in tablets by HPLC,
Zhongguo Yiyao Gongye Zazhi. 27 (1996) 411-413.
[282] A.B. Avadhanulu, J.S. Srinivas, Y. Anjaneyulu, Reverse phase HPLC
determination of Amlodipine besylate in drug and its pharmaceutical dosage
forms, Indian Drugs. 33 (1996) 36-40.
[283] A. Alsarra Ibrahim, High-performance liquid chromatographic method for
quantitative determination of amlodipine in human plasma and pharmaceutical
dosage form and its application to pharmacokinetic studies, Journal of
chromatographic science. 47 (2009) 863-7.
[284] Malesuik Marcelo Donadel, Cardoso Simone Goncalves, Bajerski Lisiane,
Lanzanova Fibele Analine, Determination of amlodipine in pharmaceutical
dosage forms by liquid chromatography and ultraviolet spectrophotometry,
International Journal of AOAC. 89 (2006) 359-64.
[285] Varaprasad Bobbarala, Somasekhar Penumajji, K. Useni Reddy Mallu,
Hussain Reddy, HPLC Method Development for Glucosamine Sulphate and
Diacerein Formulation, Journal of Pharmacy Research, Journal of Pharmacy
Research. 3 (2010) 361-363.
[286] A. Praneeth Kumar, P. Sunil Kumar Chaitanya, G. Rohini Reddy, S.K.
Umadevi, Method development & validation for simultaneous estimation of
diacerin and glucosamine sulphate by RP HPLC in bulk and tablet dosage
form, IAJPR. 4 (2014) 1369-1377.
[287] N. Kannappan, A.R. Madhukar, R.L.A. Srinivasan, Ch. Naveen kumar,
Mannavalan, analytical method development and validation of diacerein
175
tablets byRP-HPLC, International Journal of Chemical Technology Research.
2 (2010) 143-148.
[288] Purnima Hamrapurkar, Priti Patil, Sandeep Pawar, Stress degradation studies
and development of a validated stability-indicating-assay-method for
determination of diacerein in presence of degradation products,
Pharmaceutical methods. 2 (2011) 30-35.
[289] Thamma Narendra kumar, R. Sreenivasulu Raju, satya1, Useni Reddy Mallu,
A novel RP-HPLC method for the quantification of impurities in
glucosamine hydrochloride, International Journal of Research and Reviews in
Ppharmacy and Applied sciences. 2 (2011) 47-61.
[290] G. Ravindra babu, K.P.R. Chowdary, P. Sambasiva Rao, T.K. Preveen, V.
Ramanarayana Reddy, M. Chandrashekhar, Method development and
validation of simultaneous estimation of diacerien and aceclofenac of bulk and
pharmaceutical dosage by using rp-hplc, International Journal of Advances in
Pharmaceutical Research. 7 (2012) 996–1003.
[291] S. Patel, N.J. Patel, Simultaneous RP-HPLC and HPTLC estimation of
fluoxetine hydrochloride and olanzapine in tablet dosage forms, Indian Journal
of Pharmaceutical Sciences. 71 (2009) 477-80.
[292] B. Venkateswara Reddy, K.V.N. Suresh Reddy, J. Sreeramulu, G.V.
Kanumula, Simultaneous Determination of Olanzapine and Fluoxetine by
HPLC, Chromatographia. 66 (2007) 111-114.
[293] Pathak, S.J. Rajput, Development of a Stability-Indicating HPLC Method for
Simultaneous Determination of Olanzapine and Fluoxetine in Combined
Dosage Forms, Journal of Chromatographic Science. 47 (2009) 97-99.
[294] Charmy Shah, R. Shah, J. Nehal, Suhagi, Simultaneous Assay of Olanzapine
and Fluoxetine in Tablets by Column High-Performance Liquid
Chromatography and High-Performance Thin-Layer Chromatography, Journal
of AOAC International. 6 (2006) 204-209.
[295] A. Tantawy Mahmoud, Y. Hassan Nagiba, A. Elragehy Nariman, Mohamed
Abdelkawy, Simultaneous determination of olanzapine and fluoxetine
hydrochloride in capsules by spectrophotometry, TLC-spectrodensitometry
and HPLC, Journal of Advanced Research. 2 (2013) 173–180.
[296] S.L. Bonde, R.P. Bhadane, G.A. Avinash, S.R. Ikwad, D.U. Katale Gavali,
A.S. Narendiran, Simultaneous determination of Olanzapine and Fluoxetine
176
in human plasma by LC–MS/MS: Its pharmacokinetic application, Journal of
Pharmaceutical and Biomedical Analysis. 90 (2014) 564–71.
[297] Walter Sneader, Drug discovery: A History, Wiley, New York, 2005.
[298] O. Tournilhac, B. Cazin, S. Lepretre, M. Divine, K. Maloum, A. Delmer, B.
Grosbois, P. Feugier, F. Maloisel, F. Villard, B. Villemagne, D. Bastit, K.
Belhadj, N. Azar, M. Michallet, G. Manhes, P. Travade, Impact of frontline
fludarabine and cyclophosphamide combined treatment on peripheral blood
stem cell mobilization in B-cell chronic lymphocytic leukemia, Blood. 103
(2004) 363-5.
[299] H. Gonzalez, V. Leblond, N. Azar, L. Sutton, J. Gabarre, J.L. BinetL, J.P.
Vernant, G. Dighiero, Severe autoimmune hemolytic anemia in eight patients
treated with fludarabine, Hematol Cell Therapy. 40 (1998) 113-8.
[300] Basile, The Role of Existing and Newer Calcium Channel Blockers in the
Treatment of Hypertension, The Journal of Clinical Hypertension. 6 (2004)
621–29.
[301] Ehud Grossman, H. Franz Messerli, Calcium antagonists, Progress in
Cardiovascular Diseases. 47 (2004) 34–57.
[302] A. Claas Steven, P. Stephen Glasser, Long-acting diltiazem HCL for the
chronotherapeutic treatment of hypertension and chronic stable angina
pectoris, Expert Opinion on Pharmacotherapy. 6 (2004) 765–76.
[303] Full list of impurities found in cocaine, BBC, May 12, 2009.
[304] K.R. Hande, Etoposide: four decades of development of a topoisomerase II
inhibitor, Europian Journal of Cancer. 34 (1998) 1514–21.
[305] M. Kuhn, A. Von Wartbung, Podophyllum- Lignane: Structure and Absolute
configuration on Podorhizol-β-D-glucosid (Lignan F). 19. Mitt.
Übermitosehemmende Naturstoffe, Helvetica Chimica Acta. 50 (1967) 1546–
65.
[306] J.L. Longe Gale, Encyclopedia of Cancer: A Guide to Cancer and Its
Treatments, Detroit Thomson Gale. 2002, Pp. 397–399.
ISBN 978-1-4144-0362-5.
[307] Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug
Application, Vanda Pharmaceuticals, 11 (2007) 27.
177
[308] FDA Issues Not Approvable Letter for Iloperidone to Vanda Pharmaceuticals,
Vanda Pharmaceuticals.7 (2008) 28.
[309] Vandas Schizophrenia Drug Wins Approval from U.S. Regulators,
Bloomberg. 5 (2009).
[310] L. Scott, Iloperidone in Schizopherenia, CNS Drugs. 23(2009) 867-880.
[311] L.L. Brunton, Goodman, Gilman, The Pharmacological Basis of Therapeutics,
Twelth Edition., McGraw Hill Medical publishing division, New Delhi, 2010.
[312] A.M. Barr, S.B. Powell, A. Markou, M.A. Geyer, Iloperidone reduces
sensorimotor gating deficits in pharmacological models, but not a
developmental model, of disrupted prepulse inhibition in rats,
Neuropharmacology. 51 (2006) 457–65.
[313] M.R. Szewczak, R. Corbett, D.K. Rush, C.A. Wilmot, P.G. Conway, J.T.
Strupczewski, M. Cornfeldt, The pharmacological profile of iloperidone, a
novel atypical antipsychotic agent, The Journal of Pharmacology and
Experimental Therapeutics. 274 (1995) 1404–13.
[314] Truven health analytics, Inc. Drug point System, Cited 2013 sep 18.
[315] K. Komossa, C. Rummel Kluge, S. Schwarz, F. Schmid, H. Hunger, W.
Kissling, S. Leucht,Risperidone versus other atypical antipsychotics for
schizopherenia, The Cochrane database of systematic reviews (1): CD006626.
Doi: 10.1002/14651858.CD006626.pub2.
[316] WHO Model List of Essential Medicines, World Health Organization. October
2013. Retrived 22 April 2014.
[317] Risperdal at naminh.org/resources.
[318] Respiridone, The American Society of Health system Pharmacists, 2011.
[319] R.D. Rattehalli, M.B. Jayaram, M. Smith, Ranganath, ed. Cochrane Database
System revision (1): CD006918, 2010.
[320] A.R. Maher, G. Theodore, Summary of the comparative effectiveness review
in off- label use of atypical antipsychotics. J Manag Care Pharm. 18 (2012) 20.
[321] Risperdal Prescribing Information Label, Drugs@FDA: FDA Approved Drug
Products, Jannsen Pharmaceuticals, Inc, 2014.
[322] L. Brunton, B. Chabner, B. Knollman, Goodman, Gilman,The
Pharmacological Basis of Therapeutics, Twelfth Edition, McGraw Hill
Professional, 2010.
178
[323] R.M. Abou El Magd, H.K. Park, T. Kawazoe, S. Iwana, K. Ono, S.P. Chung,
M. Miyano, K. Yorita, T. Sakai, K. Fukui, The effect of risperidone on D-
amino acid oxidase activity as a hypothesis for a novel mechanism of action in
the treatment of schizophrenia, Journal of Psychopharmacology. 24 (2010) 23.
[324] E.M. Hecht, D.C. Landy, Alpha-2 receptor antagonist add-on therapy in the
treatment of schizophrenia; a meta-analysis, Schizophrenia Research. 134
(2013) 202–6.
[325] Risperidone PubMed Health. Ncbi.nlm.nih.gov, 2012.
[326] FDA Rubber Stamps APP Pharmas Generic Topotecan for Small Cell Lung
and Cervical Cancers, 30 Nov 2010.
[327] DNA Topoisomerases and Cancer, Yves Pommier Editor, Humana Press,
2012.
[328] F. Schmidt, J. Rieger, J. Wischhusen, U. Naumann, M. Weller, cell sensitivity
to topotecan: the role of p53 and topotecan-induced DNA damage, Europian
Journal of Pharmacology. 412 (2001) 21-5.
[329] S.A. Streltsov, A.L. Mikheikin, Interaction of topotecan—a DNA
topoisomerase I inhibitor—with dual-stranded polydeoxyribonucleotides. II.
Formation of a complex containing several DNA molecules in the presence of
topotecan, Mol Biol. 35 (2001) 442-50.
[330] S.A. Streltsov, Action models for the antitumor drug camptothecin: formation
of alkali-labile complex with DNA and inhibition of human DNA
topoisomerase I, Journal of Biomolecule Structure Dyn. 20 (2000) 447-54.
[331] WHO Model List of EssentialMedicines. World Health Organization. October
2013, Retrieved 22, April 2014.
[332] Amlodipine Besylate. The American Society of Health-System Pharmacists.
Retrieved 3 April 2011.
[333] J.G. Wang, Vascular health and risk management. 5 (2009) 593–605.
[334] WWW.Sandoz product information sheet.
[335] Harry Gouvas, Use of Sodium Hyaluronate in the treatment of Osteoarthritis,
Greece, 2011.
[336] T.S. Fidelix, B.G. Soares, V.F. Trevisani, Diacerein for osteoarthritis,
Cochrane database of systematic reviews (Online), 1, 2006.
179
[337] J.P. Pelletier, Efficacy and safety of diacerein in osteoarthritis of the knee: a
double-blind, placebo-controlled trial. The Diacerein Study Group, Arthritis
Rheumatology. 43 (2000) 2339-48.
[338] Georg Ledderhose, Uber salzsaures Glycosamine, Berichte der deutschen
chemischen Gesellschaft. 9 (1876) 1200–1201.
[339] G. Ledderhose, Uber Chitin und seine Spaltungs produkte, Zeitschrift fur
physiologische Chemie, 2 (1878) 213–227.
[340] G. Ledderhose, Uber Chitin und seine Spaltungs produkte, Uber Glykosamin
Zeitschrift fur physiologische Chemie. 2 (1880) 139–159.
[341] W.W. Pigman, D. Horton, J.D. Wander, The Carbohydrates, Academic Press,
Vol IB, New York, 1980, Pp. 727–728.
[342] W.N. Haworth, W.H.G. Lake, S.Peat, The configuration of glucosamine
(chitosamine), Journal of the Chemical Society. (1939) 271–274.
[343] Gary Mc Farlane, Journal of osteoarthritis and fibromyalgia. ARC (2010) 44–
46.
[344] M. Lafontaine Lacasse, M. Dore, F. Picard, Hexosamines stimulate apoptosis
by altering Sirt1 action and levelsin rodent pancreatic β-cells, Journal of
Endocrinology. 208 (2011) 41–9.
[345] S. Leucht, A. Cipriani, L. Spineli, Comparative efficacy and tolerability of 15
antipsychotic drugs in schizophrenia: a multiple treatments meta analysis,
Lancet. 382 (2013) 951–62.
[346] D.N. Osser, M.J. Roudsari, T. Manschreck, The psychopharmacology
algorithm project at the Harvard South Shore Program: an update on
schizophrenia, Harv Rev Psychiatry. 21 (2013) 18–40.
[347] J.P. Zhang, J.A. Gallego, D.G. Robinson, A.K. Malhotra, J.M. Kane, C.U.
Correll, Efficacy and safety of individual second-generation vs first-generation
antipsychotics in first-episode psychosis: a systematic review and meta-
analysis, International Journal of Neuropsychopharmacology. 16 (2013) 1205–
18.
[348] L. Citrome, A systematic review of meta-analyses of the efficacy of oral
atypical antipsychotics for the treatment of adult patients with schizophrenia,
Expert Opin Pharmacother. 13 (2012) 1545–73.
180
[349] P. Lepping, R.S. Sambhi, R. Whittington, S. Lane, R. Poole, Clinical
relevance of findings in trials of antipsychotics: systematic review, British
Journal of Psychiatry. 198 (2011) 341–5.
[350] S. Leucht, A. Cipriani, L. Spineli, D. Mavridis, D. Orey, F. Richter,
Comparative efficacy and tolerability of 15 antipsychotic drugs in
schizophrenia: a multiple-treatments meta-analysis, The Lancet. 382 (2013)
951–62.
[351] C. Stollberger, W. Lutz, J. Finsterer, Heat-related side-effects of neurological
and non-neurological medication may increase heatwave fatalities, European
Journal of Neurology. 16 (2009) 879–882.
[352] OLANZAPINE tablet, orally disintegrating, DailyMed. Prasco Laboratories.
September 2013. Retrieved 26 November 2013.
[353] Olanzapine 10 mg tablets - Summary of Product Characteristics, electronic
Medicines Compendium. Aurobindo Pharma - Milpharm Ltd, 2013.
[354] T. Wong David, S. Horng Jong, P. Bymaster Frank, L. Hauser Kenneth,
Molloy, B. Bryan, A selective inhibitor of serotonin uptake: Lilly 110140, 3-
(p-Trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine, Life Sciences.
15 (1974) 471–9.
[355] Randi Jenssen Hagerman, Dech, Budow, Anecdotal use of fluoxetine in a case
of PWS to control behavior problems, appetite, and trichotillomania,
Neurodevelopmental Disorders: Diagnosis and Trea.tment. Oxford University
Press. 1999.
[356] K. Williams, Selective serotonin reuptake inhibitors for autism spectrum
disorders, Cochrane Database Systematic Review, 8, 2010.
[357] S.M. Myers, The status of pharmacotherapy for autism spectrum disorders,
Expert Opinion on Pharmacotherapy. 8 (2007) 1579–1603.
[358] C.A. Doyle, C.J. Mc Dougle, Pharmacotherapy to control behavioral
symptoms in children with autism, Expert Opinion on Pharmacotherapy. 13
(2012) 1615–1629.
[359] A. Benvenuto, B. Battan, M.C. Porfirio, P. Curatolo, Pharmacotherapy of
autism spectrum disorders, Brain and Development. 35 (2013) 119–127.
[360] A. Brayfield., Fluoxetine Hydrochloride-Martindale: The Complete Drug
Reference, Pharmaceutical Press, London, 2013.
181
[361] R.D. Bland, T.L. Clarke, L.B. Harden, Rapid infusion of sodium bicarbonate
and albumin into high-risk premature infants soon after birth: a controlled,
prospective trial, American Journal of Obstet Gynecology. 124 (1976) 263–7.
[362] M.A. Koda Kimble., B.K. Alldredge, Applied therapeutics: the clinical use of
drugs, tenth ed., Baltimore: Wolters Kluwer Health/Lippincott Williams &
Wilkins, 2012.
Recommended